Covered recipient · General Payments record
JANET BRADSHAW
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2021
$311.52
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $159.24 | 12 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $36.58 | 3 |
| Novo Nordisk AS | $31.23 | 2 |
| Lilly USA, LLC | $25.21 | 2 |
| ABBVIE INC. | $25.05 | 2 |
| Daiichi Sankyo Inc. | $24.68 | 2 |
| Amgen Inc. | $16.49 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $13.09 | 07/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794132285 | CMS |
| AbbVie Inc. | $11.96 | 09/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794132289 | CMS |
| Amgen Inc. | $16.49 | 09/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825387205 | CMS |
| Daiichi Sankyo Inc. | $12.87 | 04/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836285849 | CMS |
| Daiichi Sankyo Inc. | $11.81 | 06/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 836301241 | CMS |
| Lilly USA, LLC | $12.50 | 04/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818551149 | CMS |
| Lilly USA, LLC | $12.71 | 07/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818559843 | CMS |
| Merck Sharp & Dohme Corporation | $12.54 | 03/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848605933 | CMS |
| Merck Sharp & Dohme Corporation | $11.92 | 05/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848327677 | CMS |
| Merck Sharp & Dohme Corporation | $12.12 | 08/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 848689903 | CMS |
| Novo Nordisk Inc | $16.32 | 01/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811003831 | CMS |
| Novo Nordisk Inc | $14.91 | 03/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811082232 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.